1. Home
  2. VERA vs ASTH Comparison

VERA vs ASTH Comparison

Compare VERA & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • ASTH
  • Stock Information
  • Founded
  • VERA 2016
  • ASTH 1994
  • Country
  • VERA United States
  • ASTH United States
  • Employees
  • VERA N/A
  • ASTH N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • ASTH Professional Services
  • Sector
  • VERA Health Care
  • ASTH Consumer Discretionary
  • Exchange
  • VERA Nasdaq
  • ASTH Nasdaq
  • Market Cap
  • VERA 2.5B
  • ASTH 2.2B
  • IPO Year
  • VERA 2021
  • ASTH N/A
  • Fundamental
  • Price
  • VERA $42.01
  • ASTH $55.47
  • Analyst Decision
  • VERA Strong Buy
  • ASTH Strong Buy
  • Analyst Count
  • VERA 9
  • ASTH 6
  • Target Price
  • VERA $53.56
  • ASTH $64.40
  • AVG Volume (30 Days)
  • VERA 683.6K
  • ASTH 269.1K
  • Earning Date
  • VERA 11-07-2024
  • ASTH 11-07-2024
  • Dividend Yield
  • VERA N/A
  • ASTH N/A
  • EPS Growth
  • VERA N/A
  • ASTH 45.24
  • EPS
  • VERA N/A
  • ASTH 1.44
  • Revenue
  • VERA N/A
  • ASTH $1,591,829,000.00
  • Revenue This Year
  • VERA N/A
  • ASTH $33.99
  • Revenue Next Year
  • VERA N/A
  • ASTH $24.43
  • P/E Ratio
  • VERA N/A
  • ASTH $38.79
  • Revenue Growth
  • VERA N/A
  • ASTH 22.76
  • 52 Week Low
  • VERA $9.68
  • ASTH $28.87
  • 52 Week High
  • VERA $50.78
  • ASTH $63.20
  • Technical
  • Relative Strength Index (RSI)
  • VERA 52.57
  • ASTH 47.69
  • Support Level
  • VERA $39.22
  • ASTH $54.81
  • Resistance Level
  • VERA $50.00
  • ASTH $57.09
  • Average True Range (ATR)
  • VERA 2.41
  • ASTH 1.75
  • MACD
  • VERA 0.24
  • ASTH -0.71
  • Stochastic Oscillator
  • VERA 28.53
  • ASTH 22.13

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About ASTH Astrana Health Inc. Common Stock

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.

Share on Social Networks: